Skip to main content
Watch Insiders
PCSA filings

Corporate insider profile

Patrick Lin Filing Activity

Latest reported as Chief Business - Strategy Off of Processa Pharmaceuticals, Inc. (PCSA).

Purchase filings
5
Reported companies
1
Net open-market value
$20,327
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

PCSALatest reported

Processa Pharmaceuticals, Inc.

Chief Business - Strategy Off

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase1,831$2.22$4,065
May 29, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase1,582$2.57$4,066
May 15, 2026Processa Pharmaceuticals, Inc. (PCSA)Chief Business - Strategy OffOpen Market Purchase1,369$2.97$4,066
Subscribe to see more data